Table 3.
First Set of Models | Second Set of Models | ||||||
---|---|---|---|---|---|---|---|
Step 1: HiTOP Dimensions | Step 2: Diagnoses | Step 1: Diagnoses | Step 2: HiTOP Dimensions | ||||
R 2 | ΔR2 | F change | R 2 | ΔR2 | F Change | R2 Step 1 HiTOP/ R2 Step 1 Diagnosis | |
Psychiatric outcomes | |||||||
Recoverya | .27*** | .04* | .14*** | .17*** | 1.91 | ||
Full symptom remissiona | .34*** | .09*** | .25*** | .18*** | 1.35 | ||
Community functioning | |||||||
Educational attainmenta | .10*** | .03 | .06* | .07** | 1.70 | ||
Employeda | .18*** | .02 | .09*** | .12*** | 2.08 | ||
Public assistancea | .24*** | .03 | .13*** | .14*** | 1.88 | ||
Role functioning | .22*** | .03* | 2.81* | .11*** | .14*** | 9.85*** | 1.98 |
Living independently | .11*** | .04* | 3.29* | .10*** | .05** | 3.46** | 1.12 |
Social functioning | .23*** | .01 | 0.99 | .06** | .18*** | 12.02*** | 3.82 |
WHO-DAS Global Disability | .15*** | .05* | 3.15* | .07** | .13*** | 7.05*** | 2.12 |
Physical health | |||||||
Diabetesa | .10** | .02 | .05 | .07* | 1.97 | ||
Hypertensiona | .05 | .02 | .02 | .05 | -- | ||
Neural responses | |||||||
MMN duration | .06* | .02 | 0.73 | .03 | .05 | 1.87 | 2.28 |
MMN frequency | .02 | .01 | 0.39 | .01 | .02 | 0.74 | -- |
P3a amplitude | .07* | .01 | 0.60 | .01 | .07* | 2.73* | 7.34 |
P3a latency | .05 | .02 | 1.09 | .02 | .06 | 2.14 | -- |
Cognitive functioning | |||||||
Cognition composite | .15*** | .09*** | 4.81*** | .17*** | .07*** | 2.53*** | 0.86 |
Note: WHO-DAS, World Health Organization Disability Assessment Schedule; MMN, Mismatched negativity; Ratio was not computed if none of the steps was significant.
aNagelkerke’s R2 estimated in logistic regression; F change can only be computed for linear regressions. See supplementary table 2 for additional logistic regression statistics.
*P < .05, **P < 01, ***P < .001.